![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Staff Writers Lima (AFP) Aug 26, 2020
Peru on Wednesday began registering volunteers for clinical trials of a Chinese vaccine against the coronavirus. Six thousand volunteers, who must be aged between 18 and 75 and not have contracted the virus, will be recruited by Cayetano Heredia and San Marcos universities via a dedicated website. "The universities will select 3,000 volunteers each," San Marcos rector Orestes Cachay told reporters. The vaccine, being developed by Chinese company Sinopharm, will be administered by injection. According to Peruvian researchers in charge of the clinical trials, two strains of the virus -- the Wuhan strain and Beijing strain -- and a placebo will be randomly given to volunteers. "A technical team from China will arrive in the coming days, totaling 38 people, to implement the operational part of the project," Cachay told TV channel N. The trial is expected to last until December President Martin Vizcarra announced last week the country would participate in clinical trials of vaccines being developed in China, Britain, the United States and Germany. Peru, with a population of 33 million, has the third-highest number of deaths from the pandemic in Latin America, after Brazil and Mexico. Per capita, it has the region's highest death rate, with 843.5 deaths per million inhabitants. More than 28,000 people have died of COVID-19 in the country, which has registered more than 600,000 infections so far.
![]() ![]() DR Congo declares end to deadly measles epidemic Kinshasa (AFP) Aug 25, 2020 The Democratic Republic of Congo (DRC) on Tuesday declared the end of a 25-month outbreak of measles that claimed the lives of more than 7,000 children aged under five. The outbreak was countered by vaccination on a massive scale, in which millions of children and infants were immunised. "For the past month, we are able to say that this epidemic has been eliminated from across our territory," Health Minister Eteni Longondo told a press conference. "We can say that measles (in the DRC) no lon ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |